CERELIFE (Cerebroprotein Hydrolysate Tablets)
Cerebroprotein Hydrolysate
Approved
Registration Information
- Food ID
- 7530
- Status
- Approved
- Application Type
- Generic/Biosimilars
- Classification
- Human
Product Information
- Active Ingredient
- Cerebroprotein Hydrolysate
- Strength
- 90 mg
- Dosage Form
- Film-Coated Tablet
- Route of Administration
- Oral
- Packaging
- 10 Tablets in one blister and such 03 blisters…
- Visual Description
- Red colour, caplet shaped, film coated tablets.…
- Shelf Life
- N/A
Manufacturer Information
- Manufacturer / Site
- Brussels Laboratories Pvt. Ltd.
- MAH (Marketing Authorization Holder)
- QUESTA CARE INC., USA
- Country
- India
- Local / Foreign
- Foreign
Record Information
- Last Fetched
- 2026-02-28 03:04:13
- Last Updated
- 2026-10-17 03:04:14
Important Notice
This information is sourced from the Pharmacy and Poisons Board of Kenya. Always consult with a qualified healthcare professional before using any supplement.